Key Points GAAP diluted earnings per share of $1.46 for Q2 2025, helped by strong day rates and one-time gains. Management reiterated full-year revenue and margin guidance, with 93% of revenue ...

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced solid results for Q2 2025 that exceeded the outlook, ...

The company reaffirmed its full-year outlook and maintained the quarterly dividend at $0.13 per share. These 10 stocks could mint the next wave of millionaires › UL Solutions (NYSE:ULS), a major ...

Pfizer beats Q2 2025 estimates, raises EPS guidance, boasts a 7%+ dividend yield, yet faces patent and pricing risks. See why ...

Wall Street analysts see strong upside for AMD ahead of Q2 results, citing data center, GPU demand, and renewed China ...

Reports Q2 revenue $101.7M, consensus $72.58M. Total revenue and net income are inclusive of $40M in non-cash contract revenue related to Rigel’s ...

Spirit AeroSystems reported 1.6 billion in revenue for the second quarter of 2025, driven by increased production of Boeing ...

Reports Q2 revenue $9.2B, consensus $8.91B. “We’re delivering strong performance and reaching more patients with innovative ...

Q3 guidance was set for EPS of $3.01–$3.07, organic growth of 8%–9%, and segment operating margins of 24.1%–24.5%. Full-year adjusted EPS guidance was raised to $11.97–$12.17, representing 12% growth ...

AMD reported its Q2 earnings after the bell on Tuesday, posting mixed results but offering a solid Q3 outlook.

Pfizer's second-quarter 2025 results exceeded expectations with a 10% revenue growth and an adjusted EPS of $0.78.

UnitedHealth Group ( NYSE: UNH) reported stronger-than-expected earnings for the second quarter of 2025, with adjusted ...